Filing Details
- Accession Number:
- 0001209191-22-054664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-10-26 17:54:01
- Reporting Period:
- 2022-10-24
- Accepted Time:
- 2022-10-26 17:54:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1596385 | Heath Lukatch | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-10-24 | 3,015 | $16.00 | 6,140 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-24 | 3,015 | $35.11 | 3,125 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-10-26 | 4,000 | $16.00 | 7,125 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-10-26 | 4,000 | $38.25 | 3,125 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-10-24 | 3,015 | $0.00 | 3,015 | $16.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-10-26 | 4,000 | $0.00 | 4,000 | $16.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 36,985 | 2030-06-10 | No | 4 | D | Direct | |
| 32,985 | 2030-06-10 | No | 4 | D | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- 1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter.
Billionaire Hedge Funds
